Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*
- Borissov, B.
- Urbich, M.
- Georgieva, B.
- Tsenov, S.
- Villa, G.
Zeitschrift:
Journal of Market Access and Health Policy
ISSN: 2001-6689
Datum der Publikation: 2017
Ausgabe: 5
Nummer: 1
Art: Artikel
